LUIS MERCADO: Open Payments
NPI 1508332305 · TURLOCK, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 31 payments from 11 companies in 2025. Trend: 2023 $44 · 2024 $55 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 12 | $292 |
| ABBVIE INC. | 5 | $105 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Novo Nordisk Inc | 2 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| Lilly USA, LLC | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $42 |
| ABIOMED | 1 | $35 |
| Exact Sciences Corporation | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
Products named: Korlym, XIFAXAN, MOUNJARO, ENTRESTO, RINVOQ, RECORLEV, Ozempic, UBRELVY.
Industry payments across CA — which companies pay providers there.
